Skip to content

Perceived Health After Hospitalization for COVID-19

Perceived Health After Hospitalization for COVID-19

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04912804
Acronym
PRO-COVID
Enrollment
207
Registered
2021-06-03
Start date
2020-06-30
Completion date
2021-05-22
Last updated
2022-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19, Post-hospitalization, Disease Impact

Brief summary

There are currently no precise data available on the impact of COVID-19 on the daily life of patients after hospitalization. For the moment, studies have only demonstrated a strong impact of the diagnosis on the domains of quality of life explored by the MOS-SF36 questionnaire and the PHQ-9 depression score. Concerning the impact of COVID-19 disease after conventional hospitalization, field reports indicate extremely intense fatigue and a major physical impact lasting several weeks

Interventions

OTHERQuestionnaires

SF-12, GHQ-12 and HAQ

Sponsors

Centre Hospitalier Universitaire Dijon
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patient * Patient with a diagnosis of COVID-19 confirmed by PCR and/or CT scan * Patient hospitalized in a short stay unit (excluding intensive care and rehabilitation) for a COVID-19 infection * Patient providing oral consent to participate in the study * Patient able to understand and answer the questionnaires used * Patient able to answer the questions on an electronic device and to receive requests by email and/or SMS * Patient who has electronic equipment at home and an Internet subscription allowing him/her to answer the questionnaires online

Exclusion criteria

* Patient under guardianship, curatorship or a measure of judicial safeguard

Design outcomes

Primary

MeasureTime frame
Time to PASS and CID in patients discharged from conventional hospitalization for COVID-19 diseaseThrough study completion, an average of 6 months
The value of perceived health scores in patients who achieved PASS and MCIIThrough study completion, an average of 6 months

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026